2007
DOI: 10.1124/jpet.107.125328
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Deletion of Ectonucleoside Triphosphate Diphosphohydrolase 1/CD39 Leads to Desensitization of Pre- and Postsynaptic Purinergic P2 Receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 42 publications
2
12
0
Order By: Relevance
“…Entpd1 null mice exhibit decreased synaptic efficacy, presumably due to desensitization P2X1 receptors (34,35). However in the cochlea, Entpd1 gene deletion had little effect, if any, on hearing, but this lack of effect may result from the coexpression of other ectonucleotidases -NTPDase2 and NTPDase8 -normally present in that epithelium (36).…”
Section: Discussionmentioning
confidence: 90%
“…Entpd1 null mice exhibit decreased synaptic efficacy, presumably due to desensitization P2X1 receptors (34,35). However in the cochlea, Entpd1 gene deletion had little effect, if any, on hearing, but this lack of effect may result from the coexpression of other ectonucleotidases -NTPDase2 and NTPDase8 -normally present in that epithelium (36).…”
Section: Discussionmentioning
confidence: 90%
“…It does not seem too far-fetched to propose that the enzymes are strategically distributed so as to influence the activity of P2 and P1 purinoceptors through the generation, or hydrolysis, of agonists such as ATP, ADP or adenosine. In addition, it is possible that ectonucleotidases prevent desensitisation of tubular P2 receptors, as has been demonstrated in other tissues [76][77][78]. Finally, it has been hypothesised that in conditions such as ischaemia, the ectonucleotidase-mediated modulation of the inhibitory effects of nucleotides on water and electrolyte reabsorption might be overwhelmed by excess ATP release, thereby reducing energy-consuming reabsorptive processes [79].…”
Section: Discussionmentioning
confidence: 97%
“…Because ATP availability greatly increases in myocardial ischemia, it has been suggested that recombinant E-NTPDase 1/CD39 may offer a novel therapeutic approach to the damage caused by ischemia by reducing sympathetic activity (Corti et al, 2011). E-NTPDase 1/CD39 deletion led to an attenuation of the activity of sympathetic pre-and postsynaptic P2X receptors (attributed to P2X receptor desensitization) perhaps because of prolonged exposure to ATP that accompanies E-NTPDase 1/CD39 deletion, and it was suggested that E-NTPDase 1/CD39 can potentially prevent the transition from myocardial ischemia to infarction (Schaefer et al, 2007).…”
Section: Ischemiamentioning
confidence: 99%